Home » Topics » Ear, nose and throat, BioWorld Science

Ear, nose and throat, BioWorld Science
RSS

Novel AAV gene therapy rescues hearing loss in Syne4-/- mice

Jan. 13, 2021

Phase I/II data shows therapeutic activity of OTO-413 across multiple speech-in-noise hearing tests

Dec. 18, 2020

Kinase inhibitor for hearing loss protection

Dec. 7, 2020

Astellas conducts phase I/II study of ASP-0598 for chronic tympanic membrane perforation

July 28, 2020

Otonomy reports treatment response in phase I/II trial of OTO-313 for tinnitus

July 7, 2020

USP48 found to be involved in hereditary hearing loss in animal model

June 12, 2020

Sensorion reports preclinical findings on otoferlin gene therapy program

June 11, 2020

Base editing gives temporary hearing fix

June 11, 2020

FDA allows phase III protocol for SPI-1005 for Meniere's disease

June 10, 2020

Otoferlin gene therapy restores hearing in congenital deafness model

May 18, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...